कृपया अन्य खोज का प्रयास करें
Kineta, Inc. is a clinical-stage biotechnology company with a focus on developing immunotherapies that transform patients' lives. It focuses on developing potentially differentiated immunotherapies that address the challenges with current cancer therapy. The company's immuno-oncology pipeline includes KVA12123, a VISTA blocking immunotherapy in development as a twice weekly monoclonal antibody (mAb) infusion drug. KVA12123 is being evaluated in a Phase 1/2 clinical trial as a monotherapy and in combination with pembrolizumab in patients with advanced solid tumors, including non-small cell lung, ovarian, renal cell carcinoma, head and neck, renal cell, and colorectal cancers. It is also developing anti-CD27 agonist mAb immunotherapy to address the problem of exhausted T cells. The company has collaboration and license agreements with MSD International Business GmbH, Genentech, Inc., FAIR Therapeutics B.V., and GigaGen, Inc. Kineta, Inc. is headquartered in Seattle, Washington.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Scott J. Dylla | - | 2023 | Director |
Michael A. Curran | - | 2020 | Member of Scientific Advisory Board |
Evan Ya-Wen Yu | - | 2023 | Member of Scientific Advisory Board |
Lisa M. Coussens | - | 2020 | Member of Scientific Advisory Board |
Patricia LoRusso | - | 2020 | Member of Scientific Advisory Board |
David A. Arkowitz | 62 | 2022 | Independent Director |
Myriam Chalabi | - | 2023 | Member of Scientific Advisory Board |
Shawn P. Iadonato | 53 | 2022 | Chairman of the Board |
Marion R. Foote | 78 | 2022 | Independent Director |
Raymond Joseph Bartoszek | 59 | 2022 | Independent Director |
Richard Peters | 61 | 2022 | Lead Independent Director |
Kimberlee Cobleigh Drapkin | 56 | 2023 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है